# REJUVEL BIO-SCIENCES, INC.

REJUVEL BIO-SCIENCES, INC. is a company headquartered in Pembroke Pines, FL, United States.

## Company overview

- **Legal name:** REJUVEL BIO-SCIENCES, INC.
- **Former names in filing history:** Technology Applications International Corp (2011-04-18 to 2015-06-11); Raj Ventures, Inc. (2010-01-19 to 2011-03-28)
- **Classification:** Company
- **Industry (SIC):** 5190 — Wholesale-Miscellaneous Nondurable Goods
- **Headquarters:** Pembroke Pines, FL, United States
- **Incorporated in:** FL
- **Fiscal year end:** December 31
- **SEC CIK:** 0001481427

## About

REJUVEL BIO-SCIENCES, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001481427, and its reported industry is Wholesale-Miscellaneous Nondurable Goods. In 10-K filed on 2015-04-17, it reported annual revenue of USD 94,096; net income of USD -352,865; total assets of USD 104,728 for the fiscal period ended 2014-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $94,096 (USD 94,096)
- **Net income:** -$352,865 (USD -352,865)
- **Total assets:** $104,728 (USD 104,728)
- **Cash and equivalents:** $39,501 (USD 39,501)
- **Operating cash flow:** -$493,785 (USD -493,785)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $51,559 (USD 51,559)
- **Net income:** -$715,546 (USD -715,546)
- **Total assets:** $105,973 (USD 105,973)
- **Cash and equivalents:** $4,891 (USD 4,891)
- **Operating cash flow:** -$297,964 (USD -297,964)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $7,979 (USD 7,979)
- **Net income:** -$834,079 (USD -834,079)
- **Total assets:** $315,430 (USD 315,430)
- **Cash and equivalents:** $120,697 (USD 120,697)
- **Operating cash flow:** -$678,982 (USD -678,982)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $1,500 (USD 1,500)
- **Net income:** -$227,838 (USD -227,838)
- **Total assets:** $198,551 (USD 198,551)
- **Cash and equivalents:** $174,363 (USD 174,363)
- **Operating cash flow:** -$211,807 (USD -211,807)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form SC 13D — filed 2017-06-08 — SCHEDULE 13D
- Form SC 13D — filed 2017-06-08 — SCHEDULE 13D
- Form 8-K — filed 2017-02-28 — period 2017-02-08 — NUUU 8-K 02/28/17
- Form 8-K — filed 2016-11-10 — period 2016-09-28 — NUUU 8-K 11/09/16
- Form 8-K — filed 2016-10-27 — period 2016-09-14 — NUUU 8-K 0/27/16
- Form 8-K — filed 2016-06-02 — period 2016-06-01 — NUUU 8-K 06/02/16
- Form SC 13G — filed 2016-01-14 — NONE
- Form 10-Q — filed 2015-11-16 — period 2015-09-30 — NUUU 10-Q 09/30/15
- Form 10-Q — filed 2015-08-19 — period 2015-06-30 — NUUU 10-Q 06/30/15
- Form SC 13G — filed 2015-08-19 — NUUU IC&EG SCHEDULE 13G
- Form SC 13G — filed 2015-08-19 — NUUU D&E SCHEDULE 13G
- Form 8-K — filed 2015-07-30 — period 2015-07-28 — NUUU 8-K 07/30/15

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/rejuvel-bio-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology